Genomic Mapping and Survival Prediction in Glioblastoma: Molecular Subclassification Strengthened by Hemodynamic Imaging Biomarkers

Abstract

The rCBV(max) measurements could be used to predict patient overall survival independent of the molecular subclasses of GBM; however, Verhaak classifiers provided additional information, suggesting that molecular markers could be used in combination with hemodynamic imaging biomarkers in the future.

References

Page 1

	Year	Citations
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma Roger Stupp, Warren Mason, Martin J. van den Bent, New England Journal of Medicine	2005	21K
Comprehensive genomic characterization defines human glioblastoma genes and core pathways Nature Neuro-oncologyGliomaTumor HeterogeneityMedicineCore Pathways	2008	7.6K
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1 Roel G.W. Verhaak, Katherine A. Hoadley, Elizabeth Purdom, Cancer Cell Neuro-oncologyOncologyTumor HeterogeneityMedicinePathology	2010	7.5K
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis Heidi Phillips, Samir Kharbanda, Ruihuan Chen, Cancer Cell Neuro-oncologyDisease ProgressionTumor HeterogeneityBrain Tumor BiologyNeural Stem Cell	2006	3.2K
Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Hannu J. Aronen, I. E. Gazit, David N. Louis, Radiology	1994	904
Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. Jerrold L. Boxerman, Kathleen M. Schmainda, Robert M. Weisskoff PubMed	2006	647
Gliomas: Predicting Time to Progression or Survival with Cerebral Blood Volume Measurements at Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging Meng Law, Robert J. Young, James S. Babb, Radiology	2008	528
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme Yu Liang, Maximilian Diehn, Nathan P. Watson, Proceedings of the National Academy of Sciences	2005	497
Identification of noninvasive imaging surrogates for brain tumor gene-expression modules Maximilian Diehn, Christine Nardini, David S. Wang, Proceedings of the National Academy of Sciences	2008	433
Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. Michael H. Lev, Yelda Özsunar, John W. Henson, PubMed	2004	411

Page 1